Literature DB >> 17430372

Mohs surgery for the treatment of melanoma in situ: a review.

Marianne Edwards Dawn1, Aerlyn G Dawn, Stanley J Miller.   

Abstract

BACKGROUND: Controversy exists in the literature regarding the use of Mohs surgery for the treatment of melanoma in situ (MIS). Mohs surgery provides the advantage of complete margin assessment; however, variations in surgical and laboratory techniques employed, make comparison of outcomes difficult.
OBJECTIVE: To review the current literature regarding Mohs surgery for treatment of MIS and to evaluate treatment options.
METHODS: We review the literature regarding traditional excision margins for MIS, the proportion of biopsy-proven MIS lesions that prove to have an invasive component, and the efficacy of Mohs surgery for MIS.
RESULTS: Many authors report a need for surgical margins larger than the recommended 5 mm, particularly with MIS arising in sun-exposed areas. Further, a review of the literature reveals that nearly one-quarter of biopsy-proven MIS lesions are found to contain invasive melanoma after complete surgical removal and pathologic examination. Substantial evidence supports the value of complete margin assessment in the treatment of MIS, particularly in the head and neck region.
CONCLUSION: Complete surgical excision with careful margin assessment is required to adequately treat MIS lesions, particularly given the high rate of invasive melanoma in lesions initially thought to be MIS. Mohs surgery remains the treatment of choice for all clinically ill-defined MIS.

Entities:  

Mesh:

Year:  2007        PMID: 17430372     DOI: 10.1111/j.1524-4725.2007.33085.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  12 in total

1.  Cutaneous melanoma in situ: translational evidence from a large population-based study.

Authors:  Simone Mocellin; Donato Nitti
Journal:  Oncologist       Date:  2011-05-31

2.  Management of cutaneous tumors with mohs micrographic surgery.

Authors:  Krisinda C Dim-Jamora; Jennifer B Perone
Journal:  Semin Plast Surg       Date:  2008-11       Impact factor: 2.314

3.  Immunohistochemistry in mohs micrographic surgery: a review of the literature.

Authors:  Novie Sroa; Shannon Campbell; Larisa Ravitskiy
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

4.  Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.

Authors:  Adi Nosrati; Jacqueline G Berliner; Shilpa Goel; Joseph McGuire; Vera Morhenn; Juliana R de Souza; Yildiray Yeniay; Rasnik Singh; Kristina Lee; Mio Nakamura; Rachel R Wu; Ann Griffin; Barbara Grimes; Eleni Linos; Mary Margaret Chren; Roy Grekin; Maria L Wei
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

5.  Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.

Authors:  Sheila M Valentín-Nogueras; David G Brodland; John A Zitelli; Lorena González-Sepúlveda; Cruz M Nazario
Journal:  Dermatol Surg       Date:  2016-06       Impact factor: 3.398

Review 6.  Histopathologic pitfalls of Mohs micrographic surgery and a review of tumor histology.

Authors:  Katlein França; Yasser Alqubaisy; Ashraf Hassanein; Keyvan Nouri; Torello Lotti
Journal:  Wien Med Wochenschr       Date:  2016-11-10

7.  Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

Authors:  Qing Fan; Stephanie Cohen; Becky John; Adam I Riker
Journal:  Ochsner J       Date:  2015

Review 8.  [Malignant head and neck melanoma: Part 2: Therapy].

Authors:  C Pföhler; T Vogt; C S L Müller
Journal:  HNO       Date:  2015-08       Impact factor: 1.284

9.  Analysis of skin lesions using laminar optical tomography.

Authors:  Timothy J Muldoon; Sean A Burgess; Brenda R Chen; Désirée Ratner; Elizabeth M C Hillman
Journal:  Biomed Opt Express       Date:  2012-06-22       Impact factor: 3.732

10.  Lentigo maligna mimicking invasive melanoma in Mohs surgery: a case report.

Authors:  Teresa Tsakok; Nisith Sheth; Alistair Robson; Catherine Gleeson; Raj Mallipeddi
Journal:  F1000Res       Date:  2014-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.